Systemic thromboses after cardiopulmonary bypass: Is it thrombin or antithrombin? [3]

Anesthesiology

Volumn 105, Issue 2, 2006, Pages 428-

  Tanaka, Kenichi A ^a   Sniecinski, Roman ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN III CONCENTRATE; APROTININ; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; THROMBATE III; THROMBIN; THROMBOCYTE CONCENTRATE;

ANTICOAGULANT THERAPY; CARDIOPULMONARY BYPASS; DEEP VEIN THROMBOSIS; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG EFFICACY; HUMAN; LETTER; POSTOPERATIVE THROMBOSIS; PRIORITY JOURNAL; SYSTEMIC DISEASE;

ANTICOAGULANTS; ANTITHROMBINS; APROTININ; CARDIOPULMONARY BYPASS; DRUG RESISTANCE; HEMOSTATICS; HEPARIN; HUMANS; POSTOPERATIVE COMPLICATIONS; THROMBIN; THROMBOSIS;

EID: 33746623695     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/00000542-200608000-00030     Document Type: Letter

References (9)

1. Augoustides JG, Lin J, Gambone AJ, Cheung AT: Fatal thrombosis in an adult after thoracoabdominal aneurysm repair with aprotinin and deep hypothermic circulatory arrest. ANESTHESIOLOGY 2005; 103:215-6
2. Augoustides JG, Kilbaugh T, Harris H, Glick JH, Acker M, Savino JS: Fatal thrombosis after mitral valve replacement for endocarditis: Aprotinin and disseminated intravascular coagulation (letter). ANESTHESIOLOGY 2006; 104:213
3. Despotis GJ, Joist JH, Hogue CW Jr, Alsoufiev A, Kater K, Goodnough LT, Santoro SA, Spitznagel E, Rosenblum M, Lappas DG: The impact of heparin concentration and activated clotting time monitoring on blood conservation: A prospective, randomized evaluation in patients undergoing cardiac operation. J Thorac Cardiovasc Surg 1995; 110:46-54
4. Tanaka KA, Szlam F, Katori N, Sato N, Vega JD, Levy JH: The effects of argatroban on thrombin generation and hemostatic activation in vitro. Anesth Analg 2004; 99:1283-9
5. Heindel SW, Mill MR, Freid EB, Valley RD, White GC II, Norfleet EA: Fatal thrombosis associated with a hemi-Fontan procedure, heparin-protamine reversal, and aprotinin. ANESTHESIOLOGY 2001; 94:369-71
6. Fanashawe MP, Shore-Lesserson L, Reich DL: Two cases of fatal thrombosis after aminocaproic acid therapy and deep hypothermic circulatory arrest. ANESTHESIOLOGY 2001; 95:1525-7
7. Chun R, Poon MC, Haigh J, Seal D, Donahue B, Royston D: Case 1-2005: Cardiac surgery in congenital afibrinogenemia with thrombo-occlusive disease. J Cardiothorac Vasc Anesth 2005; 19:109-17
8. Shiga T, Wajima Z, Inoue T, Sakamoto A: Aprotinin in major orthopedic surgery: A systematic review of randomized controlled trials. Anesth Analg 2005; 101:1602-7
9. Avidan MS, Levy JH, Scholz J, Delphin E, Rosseel PM, Howie MB, Gratz I, Bush CR, Skubas N, Aldea GS, Licina M, Bonfiglio LJ, Kajdasz DK, Ott E, Despotis GJ: A phase III, double-blind, placebo-controlled, multicenter study on the efficacy of recombinant human antithrombin in heparin-resistant patients scheduled to undergo cardiac surgery necessitating cardiopulmonary bypass. ANESTHESIOLOGY 2005; 102:276-84